AB
KERX

Amalgamated Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Amalgamated Bank’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14,281
Closed -$54K – 1725
2018
Q2 		$54K Buy
14,281
+2,418
+20% +$11.8K ﹤0.01% 1695
2018
Q1 		$49K Sell
11,863
-329
-3% -$1.53K ﹤0.01% 1571
2017
Q4 		$57K Buy
12,192
+752
+7% +$4.14K ﹤0.01% 1604
2017
Q3 		$81K Buy
11,440
+893
+8% +$6.42K ﹤0.01% 1525
2017
Q2 		$76K Buy
+10,547
New +$65.9K ﹤0.01% 1529
2016
Q2 		– Sell
-10,906
Closed -$51K – 1414
2016
Q1 		$51K Buy
+10,906
New +$43.5K 0.01% 1255
2015
Q4 		– Sell
-10,912
Closed -$38K – 1289
2015
Q3 		$38K Buy
10,912
+194
+2% +$1.3K ﹤0.01% 1274
2015
Q2 		$107K Buy
10,718
+571
+6% +$6.12K 0.01% 1300
2015
Q1 		$129K Buy
+10,147
New +$130K 0.02% 900

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's KERX Position: Q3 2018 in Review

Amalgamated Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 14,281 shares — an estimated $54K sold.

Amalgamated Bank first reported a position in KERX in Q1 2015 and held it in 9 quarters. The position peaked at $129K in Q1 2015. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.

  • Amalgamated Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Amalgamated Bank sold 14,281 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $54K.
  • Amalgamated Bank first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 9 quarters.
  • Amalgamated Bank's Keryx Biopharmaceuticals Inc position peaked at $129K in Q1 2015.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.

Based on Amalgamated Bank's 13F filing for Q3 2018, filed 14 Nov 2018.